INS and Insulin resistance: Removal of senescent cells using this mouse model on adult HFD mice (7-8 months) or mice with insulin resistance induced by S961 treatment, mitigates glucose intolerance, restores insulin sensitivity concomitant with a reduction in the markers of proinflammatory senescent β-cells in mouse islets (2).